Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratolytic is not a specific molecule or receptor but rather a functional class describing agents—often drugs or enzymes—that promote the softening, breakdown, and shedding of the outermost layer of the skin (the stratum corneum). These agents are used therapeutically to treat rough or scaly skin conditions by facilitating exfoliation. Common examples include salicylic acid and lactic acid. Some keratolytics act enzymatically (e.g., certain proteases like keratinase), while others are chemical compounds. They do not represent a single molecular target but rather a group defined by their effect on keratinized tissue.
Soften and break down the keratinized outer layer of the skin (stratum corneum), promoting exfoliation and removal of dead cells
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratolytic agent.